TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CCAP Stock 12 Month Forecast
Average Price Target
$16.17
▲(10.38% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Crescent Capital BDC in the last 3 months. The average price target is $16.17 with a high forecast of $19.00 and a low forecast of $14.00. The average price target represents a 10.38% change from the last price of $14.65.
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Crescent Capital BDC (CCAP)CCAP /Specialty Finance ( BUY; PT: $16.00 ) ... CCAP reported 3Q25 net investment income with diluted EPS, and we maintain our Buy rating.
Analysts Offer Insights on Financial Companies: Crescent Capital BDC (NASDAQ: CCAP), Eagle Point Credit Company (NYSE: ECC) and Bitfarms (NASDAQ: BITF)
Oppenheimer Sticks to Its Buy Rating for Crescent Capital BDC (CCAP)
Unknown Analyst
Clear Street
Not Ranked
Clear Street
$16.5→$15.5
Buy
5.80%
Upside
Reiterated
11/14/25
Crescent Capital BDC (CCAP) Receives a Buy from Clear StreetWe lower our price target to $15.50 (from $16.50), based on an 0.80x target P/NAV and 11.8% implied yield, maintaining our Buy rating.
Crescent Capital BDC (CCAP) Gets a Buy from Raymond JamesWe maintain our Outperform rating and our target price at $17/share on Crescent Capital BDC, Inc. (CCAP).
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Crescent Capital BDC (CCAP)CCAP /Specialty Finance ( BUY; PT: $16.00 ) ... CCAP reported 3Q25 net investment income with diluted EPS, and we maintain our Buy rating.
Analysts Offer Insights on Financial Companies: Crescent Capital BDC (NASDAQ: CCAP), Eagle Point Credit Company (NYSE: ECC) and Bitfarms (NASDAQ: BITF)
Oppenheimer Sticks to Its Buy Rating for Crescent Capital BDC (CCAP)
Unknown Analyst
Clear Street
Not Ranked
Clear Street
$16.5→$15.5
Buy
5.80%
Upside
Reiterated
11/14/25
Crescent Capital BDC (CCAP) Receives a Buy from Clear StreetWe lower our price target to $15.50 (from $16.50), based on an 0.80x target P/NAV and 11.8% implied yield, maintaining our Buy rating.
Crescent Capital BDC (CCAP) Gets a Buy from Raymond JamesWe maintain our Outperform rating and our target price at $17/share on Crescent Capital BDC, Inc. (CCAP).
trades and holding each position for 1 Month would result in 85.71% of your transactions generating a profit, with an average return of +4.91% per trade.
trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +1.57% per trade.
Copying Mitchel Penn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.69% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +34.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CCAP Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
5
6
5
5
7
Hold
4
3
4
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
9
9
11
14
In the current month, CCAP has received 7Buy Ratings, 7Hold Ratings, and 0Sell Ratings. CCAP average Analyst price target in the past 3 months is 16.17.
Each month's total comprises the sum of three months' worth of ratings.
CCAP Financial Forecast
CCAP Earnings Forecast
Next quarter’s earnings estimate for CCAP is $0.43 with a range of $0.41 to $0.47. The previous quarter’s EPS was $0.46. CCAP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year CCAP has Performed in-line its overall industry.
Next quarter’s earnings estimate for CCAP is $0.43 with a range of $0.41 to $0.47. The previous quarter’s EPS was $0.46. CCAP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year CCAP has Performed in-line its overall industry.
CCAP Sales Forecast
Next quarter’s sales forecast for CCAP is $40.08M with a range of $39.30M to $41.30M. The previous quarter’s sales results were $36.45M. CCAP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year CCAP has Performed in-line its overall industry.
Next quarter’s sales forecast for CCAP is $40.08M with a range of $39.30M to $41.30M. The previous quarter’s sales results were $36.45M. CCAP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year CCAP has Performed in-line its overall industry.
CCAP Stock Forecast FAQ
What is CCAP’s average 12-month price target, according to analysts?
Based on analyst ratings, Crescent Capital Bdc, Inc.’s 12-month average price target is 16.17.
What is CCAP’s upside potential, based on the analysts’ average price target?
Crescent Capital Bdc, Inc. has 10.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CCAP a Buy, Sell or Hold?
Crescent Capital Bdc, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is Crescent Capital Bdc, Inc.’s price target?
The average price target for Crescent Capital Bdc, Inc. is 16.17. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $19.00 ,the lowest forecast is $14.00. The average price target represents 10.38% Increase from the current price of $14.65.
What do analysts say about Crescent Capital Bdc, Inc.?
Crescent Capital Bdc, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of CCAP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.